Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Upton

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|June 13, 2014
Tuberculosis drug discovery and emerging targetsKhisimuzi Mdluli, Takushi Kaneko, Anna Upton
Cold Spring Harbor Perspectives in Medicine|January 31, 2015
The tuberculosis drug discovery and development pipeline and emerging drug targetsKhisimuzi Mdluli, Takushi Kaneko, Anna Upton
Protein Expression and Purification|January 3, 2003
Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferaseAkane Kawamura, James Sandy, Anna Upton, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
A stochastic simulation-based approach to inform the relapsing mouse model study design for non-clinical assessment of tuberculosisJames Clary, Jessica K Roberts, Debra Hanna, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of TuberculosisRokeya Tasneen, Deborah S Mortensen, Paul J Converse, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis ModelSi-Yang Li, Paul J Converse, Fabrice Betoudji, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Identification and optimization of a new series of anti-tubercular quinazolinonesCédric Couturier, Christine Lair, Alain Pellet, et al.
Cell|February 24, 2023
Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agentsJidong Zhang, Christine Lair, Christine Roubert, et al.
Science Advances|March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferaseAmrita Singh, Samantha Ottavi, Inna Krieger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|June 13, 2014
Tuberculosis drug discovery and emerging targetsKhisimuzi Mdluli, Takushi Kaneko, Anna Upton
Cold Spring Harbor Perspectives in Medicine|January 31, 2015
The tuberculosis drug discovery and development pipeline and emerging drug targetsKhisimuzi Mdluli, Takushi Kaneko, Anna Upton
Protein Expression and Purification|January 3, 2003
Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferaseAkane Kawamura, James Sandy, Anna Upton, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
A stochastic simulation-based approach to inform the relapsing mouse model study design for non-clinical assessment of tuberculosisJames Clary, Jessica K Roberts, Debra Hanna, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of TuberculosisRokeya Tasneen, Deborah S Mortensen, Paul J Converse, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis ModelSi-Yang Li, Paul J Converse, Fabrice Betoudji, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Identification and optimization of a new series of anti-tubercular quinazolinonesCédric Couturier, Christine Lair, Alain Pellet, et al.
Cell|February 24, 2023
Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agentsJidong Zhang, Christine Lair, Christine Roubert, et al.
Science Advances|March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferaseAmrita Singh, Samantha Ottavi, Inna Krieger, et al.
Pageof 1